Investor Presentaiton

Investor Presentation First nine months of 2018 Slide 78 The GLP-1 segment accounts for around 12% of total diabetes care market value in Region Europe GLP-1 value in bDKK European GLP-1 market Victoza® Exenatide Dulaglutide Other VictozaⓇ value market share in Region Europe Victoza® Exenatide Dulaglutide Other 89 654321 0 Aug 2013 CAGR value¹: 20.4% 1 CAGR for 5-year period Source: IQVIA monthly MAT Aug, 2018 value figures (DKK) changing diabetes® Share of total diabetes care market GLP-1 value market share 10% 100% 8% 80% + 6% 60% +4% 40% 2% 20% 0% 0% Aug 2018 Aug 2013 Source: IQVIA monthly MAT Aug, 2018 value figures (DKK) 55% 32% 11% 2% Aug 2018 novo nordisk

View entire presentation